Lyra Therapeutics, Inc. (LYRA)
NASDAQ: LYRA · Real-Time Price · USD
0.189
+0.007 (3.90%)
At close: Nov 22, 2024, 4:00 PM
0.186
-0.003 (-1.53%)
After-hours: Nov 22, 2024, 4:11 PM EST
Lyra Therapeutics Market Cap
Lyra Therapeutics has a market cap or net worth of $12.37 million as of November 22, 2024. Its market cap has decreased by -91.97% in one year.
Market Cap
12.37M
Enterprise Value
-3.93M
1-Year Change
-91.97%
Ranking
Category
Stock Price
$0.19
Market Cap Chart
Since May 1, 2020, Lyra Therapeutics's market cap has decreased from $230.14M to $12.37M, a decrease of -94.62%. That is a compound annual growth rate of -47.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 11.65M | -95.77% |
| Dec 29, 2023 | 275.43M | 175.60% |
| Dec 30, 2022 | 99.94M | 76.26% |
| Dec 31, 2021 | 56.70M | -61.52% |
| Dec 31, 2020 | 147.37M | -35.97% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Trinity Biotech | 12.49M |
| QT Imaging Holdings | 12.17M |
| Talphera | 12.07M |
| AIM ImmunoTech | 12.03M |
| China Jo-Jo Drugstores | 11.80M |
| ImmunoPrecise Antibodies | 11.38M |
| Immuron | 11.21M |
| Indaptus Therapeutics | 10.81M |